Management of the no-reflow phenomenon
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference162 articles.
1. Features and outcome of no-reflow after percutaneous coronary intervention;Abbo;Am J Cardiol,1995
2. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14;Ames;Nature,1999
3. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial;Amit;Am Heart J,2006
4. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes;Annex;Circulation,1995
5. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group;TIMI Study Group;N Engl J Med,1985
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intracoronary adenosine compared with adrenaline and verapamil in the treatment of no-reflow phenomenon following primary PCI in STEMI patients;International Journal of Cardiology;2024-09
2. Growth differentiation factor-15 as a biomarker of coronary microvascular dysfunction in ST-segment elevation myocardial infarction;Heliyon;2024-08
3. The non-HDL-C/HDL-C ratio is a strong and independent predictor of the no-reflow phenomenon in patients with ST-elevation myocardial infarction;Acta Cardiologica;2024-01-04
4. A New Inflammatory Marker of the No-reflow Phenomenon after Percutaneous Coronary Intervention (PCI) to Saphenous Venous in Patients with Coronary Artery Disease;Iranian Red Crescent Medical Journal;2023-12-09
5. Chinese Expert Consensus on Microvascular Protection Strategy during Emergency Percutaneous Coronary Intervention Therapy in Patients with ST-elevation Myocardial Infarction;Cardiology Discovery;2023-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3